Alerus Financial’s GlucoTrack GCTK Stock Holding History

Alerus Financial’s Portfolio GCTK Stock Details GCTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.28K	Hold	267	–	–	﹤0.01%	463
2026 Q1	$2.6K	Hold	267	–	–	﹤0.01%	444
2025 Q4	$15.5K	Sell	267 -66	-20%	-$5.88K	﹤0.01%	320
2025 Q3	$33K	Buy	+333	New	+$30.1K	﹤0.01%	287
2025 Q2	–	Sell	-333	Closed	-$52.4K	–	511
2025 Q1	$52.4K	Buy	333 +332	+33,200%	+$335K	﹤0.01%	158
2024 Q4	$5.17K	Hold	1	–	–	﹤0.01%	157
2024 Q3	$33.4K	Hold	1	–	–	﹤0.01%	155
2024 Q2	$27.8K	Hold	1	–	–	﹤0.01%	156
2024 Q1	$22.9K	Hold	1	–	–	﹤0.01%	160
2023 Q4	$18.1K	Hold	1	–	–	﹤0.01%	150
2023 Q3	$18.2K	Hold	1	–	–	﹤0.01%	152
2023 Q2	$23.9K	Buy	+1	New	+$53.9K	﹤0.01%	157
2023 Q1	–	Hold	0	–	–	–	163
2022 Q4	–	Hold	0	–	–	–	164
2022 Q3	–	Hold	0	–	–	–	150

Other funds holding GCTK

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

GIPW

Granite Islands Private Wealth Guilford, Connecticut $135M AUM

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Alerus Financial's GCTK Position: Q2 2026 in Review

Alerus Financial held its GlucoTrack (GCTK) position steady in Q2 2026 at 267 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Alerus Financial first reported a position in GCTK in Q2 2023 and has held it in 12 quarters since. The position peaked at $52.4K in Q1 2025. 18 funds tracked by Wall St. Rank hold GCTK as of Q2 2026.

Alerus Financial held 267 shares of GlucoTrack worth $1.28K as of Q2 2026.
Alerus Financial left its GlucoTrack share count unchanged in Q2 2026.
GlucoTrack made up ﹤0.01% of Alerus Financial's portfolio in Q2 2026, its #463 holding.
Alerus Financial first reported a position in GlucoTrack in Q2 2023 and has held it in 12 quarters since.
Alerus Financial's GlucoTrack position peaked at $52.4K in Q1 2025.
18 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2026.

Based on Alerus Financial's 13F filing for Q2 2026, filed 14 Aug 2026.